Company: PCRX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001104659-25-041219
Chunk: 86

Company: Pacira BioSciences, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 86
---
 Margins | ​ | ​ | Pipeline Development Milestones       | ​ |
| ​ | Adjusted Earnings Per Share          | ​ | ​ | Commercial Manufacturing Goals        | ​ |
| ​ | ​                                    | ​ | ​ | People and Organizational Goals       | ​ |

90 | investor.pacira.com

TABLE OF CONTENTS Executive Compensation PAY VERSUS PERFORMANCE: TOTAL SHAREHOLDER RETURN The chart below compares the CAP to our PEOs and the average CAP to our non-PEO NEOs with the TSR of the Company and its selected peer group—the S&P Pharmaceuticals Select Index. As described on page 68, this index is the same one used in our cash LTIP plan. Pacira BioSciences, Inc. 2025 Proxy Statement | 91 TABLE OF CONTENTS Executive Compensation PAY VERSUS PERFORMANCE: NET INCOME (LOSS) The chart below compares the CAP to our PEOs and the average CAP to our non-PEO NEOs with the Company’s net income (loss). Included in net income in 2020 was a $ 126.6million income tax benefit related to the release of a valuation allowance on deferred tax assets. Included in net loss in 2024 was a $ 163.2million goodwill impairment based upon an assessment that the fair value of goodwill was less than its carrying value. 92 | investor.pacira.com TABLE OF CONTENTS Executive Compensation PAY VERSUS PERFORMANCE: ADJUSTED EBITDA
(NON-GAAP) The chart below compares the CAP to our PEOs and the average CAP to our non-PEO NEOs with the Company’s adjusted EBITDA, which includes GAAP to non-GAAP adjustments that reflect how the Company’s management analyzes its financial results. The adjusted EBITDA figures presented here are unlikely to be comparable with adjusted EBITDA disclosures released by other companies or us in other contexts. Pacira BioSciences, Inc. 2025 Proxy Statement | 93

TABLE OF CONTENTS Executive Compensation

CHIEF EXECUTIVE OFFICER Pay Ratio Pursuant to Section 953(b) of Dodd-Frank and Item 402(u) of Regulation S-K, we are required to disclose the ratio of our principal executive officer’s annual total compensation to the annual total compensation of our median employee. For 2024, the annual total compensation for our chief executive officer, Frank D. Lee, was $15,944,347. The annual total compensation for our median employee (identified as